kabutan

Noile-Immune Biotech, First Half Ordinary Profit Loss Narrows, Apr-Jun Ordinary Profit Loss Narrows

Fri Aug 8, 2025 3:45 pm JST Earnings

4893 Noile-Immune Biotech Inc. 【J-GAAP】

Earnings Report

Noile-Immune Biotech Inc. <4893> [TSE Growth] announced its financial results after the market closed on August 8th (15:45). The ordinary loss (non-consolidated) for the cumulative second quarter of the fiscal year ending December 2025 (January to June) was a reduced loss of 410 million yen (compared to a loss of 682 million yen in the same period last year).

In the most recent three-month period, from April to June (2Q), the ordinary loss improved to a deficit of 171 million yen (compared to a loss of 343 million yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 11 -481 -832 -833 -21.0 ー Aug 10, 2023 J-GAAP
Jan - Jun, 2024 2 -681 -682 -683 -15.8 ー Aug 9, 2024 J-GAAP
Jan - Jun, 2025 4 -412 -410 -411 -9.5 ー Aug 8, 2025 J-GAAP
YoY +100.0% +39.5% +39.9% +39.8% +39.8%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 J-GAAP
Jan - Jun, 2025 Results 4 -412 -410 -411 -9.5 0 Aug 8, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 5 -388 -280 -281 -6.5 0 Feb 14, 2025 J-GAAP
Jul - Dec, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 316 -775 -1,127 -1,130 -27.3 0 Feb 13, 2024 J-GAAP
Dec, 2024 7 -1,069 -962 -964 -22.3 0 Feb 14, 2025 J-GAAP
Dec, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 0 -342 -343 -343 -7.9 -Inf Aug 9, 2024 J-GAAP
Jul - Sep, 2024 3 -211 -103 -104 -2.4 -7,033.3 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 2 -177 -177 -177 -4.1 -8,850.0 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 2 -241 -239 -240 -5.6 -12,050.0 May 12, 2025 J-GAAP
Apr - Jun, 2025 2 -171 -171 -171 -4.0 -8,550.0 Aug 8, 2025 J-GAAP
YoY － +50.0% +50.1% +50.1% +50.1%

Related Articles